Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Encabo

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Revista Espanola De Oncologia|January 1, 1983
[Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results]A Ruibal, G Encabo
Medicina Clinica|June 18, 1983
[Placental protein 5 (PP5), a new diagnostic dimension?]A Ruibal, G Encabo
Bulletin Du Cancer|January 1, 1986
Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 casesG Encabo, A Ruibal
Cancer|December 1, 1996
Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigenJ Morote, J A Lorente, G Encabo
Medicina Clinica|November 28, 1992
[Evaluation of the micro-particle enzyme immunoassay for the determination of alpha fetoprotein]G Encabo, S Aguadé, L Castells, et al.
Medicina Clinica|November 16, 1985
[Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker]A Ruibal, A Guarga, G Encabo, et al.
European Urology|July 15, 2000
Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancerJ Morote, G Encabo, I M de Torres
Presse Medicale (Paris, France : 1983)|December 21, 1985
[Serum carbohydrate antigen 19.9 in patients with digestive cancers]G Encabo, J Genolla, R Gefaell, et al.
Medicina Clinica|March 9, 1985
[Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease]A Ruibal, R Siurana, G Encabo, et al.
Medicina Clinica|February 17, 1996
[Study of the squamous cell carcinoma (SCC) antigen in benign diseases]J M Gris, J Xercavins, L Trillo, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Revista Espanola De Oncologia|January 1, 1983
[Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results]A Ruibal, G Encabo
Medicina Clinica|June 18, 1983
[Placental protein 5 (PP5), a new diagnostic dimension?]A Ruibal, G Encabo
Bulletin Du Cancer|January 1, 1986
Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 casesG Encabo, A Ruibal
Cancer|December 1, 1996
Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigenJ Morote, J A Lorente, G Encabo
Medicina Clinica|November 28, 1992
[Evaluation of the micro-particle enzyme immunoassay for the determination of alpha fetoprotein]G Encabo, S Aguadé, L Castells, et al.
Medicina Clinica|November 16, 1985
[Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker]A Ruibal, A Guarga, G Encabo, et al.
European Urology|July 15, 2000
Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancerJ Morote, G Encabo, I M de Torres
Presse Medicale (Paris, France : 1983)|December 21, 1985
[Serum carbohydrate antigen 19.9 in patients with digestive cancers]G Encabo, J Genolla, R Gefaell, et al.
Medicina Clinica|March 9, 1985
[Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease]A Ruibal, R Siurana, G Encabo, et al.
Medicina Clinica|February 17, 1996
[Study of the squamous cell carcinoma (SCC) antigen in benign diseases]J M Gris, J Xercavins, L Trillo, et al.
Pageof 7